how were glp 1 drugs discovered The transformative breakthroughs in GLP-1 research recognized by the 2024 Lasker~DeBakey award | Current Medicine Historical timeline of GLP-1 biology,

Given the relatively lower risk of these kinds of small-batch and temporary operations, it isnt legally necessary for compounders to jump through all the regulatory hoops that are required of commercial drug manufacturers to market a product, nor would it be feasible, Michael Ganio, PharmD, senior director of pharmacy practice and quality at American Society of Health-System Pharmacists, tells SELF

So the BMI is certainly a bit lower, particularly for some of the Asian population where the BMIs are actually lower regarding health risk

Safety of native glucose-dependent insulinotropic polypeptide in humans

This is the other half of the muscle-protection pair, and the evidence behind it is consistent

The grey market carries significant risks and should be approached with extreme caution